Antidote.me
Antidote.me operates a dual-sided digital health platform that connects patients with clinical trials through its Antidote Match search engine and provides precision recruitment, enterprise matching, and media services to pharmaceutical sponsors and CROs to accelerate trial enrollment.
- Company typePrivate
- Founded2010
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Antidote.me does
Antidote.me is a digital health company founded in 2010 and headquartered in New York with a UK registered office in London and a US field office in North Miami Beach, Florida. It operates a dual-sided clinical trial patient recruitment platform: the consumer-facing Antidote Match search engine lets patients find trials matched to their conditions, while sponsor-facing products — Trial Recruitment services, Enterprise Match, and Media Capabilities — help pharmaceutical sponsors and CROs accelerate enrollment. The platform ingests patient-provided data including medical conditions, history, biometrics, and genetic profiles and applies them to a precision matching workflow; a strategic partnership with SEQSTER extends the data pipeline into aggregated patient health records.
Antidote earns revenue primarily on a recurring subscription model from pharmaceutical sponsors and CROs via three streams: Trial Recruitment services, the Enterprise Match enterprise-tier recruitment platform, and Media Capabilities for patient engagement. Pricing is not publicly disclosed and is quote-based at the enterprise level. The company maintains a self-serve patient acquisition channel (clinical trial search) that feeds awareness at the top of the funnel while sponsors are reached through direct enterprise field sales and dedicated sponsor pages (e.g., /sponsors/enterprise-match).
The company has raised approximately $52.1 million in disclosed funding across six rounds between 2011 and 2021, with the most recent being a $23.2 million round in June 2021 led by LBO France, with participation from existing investors Merck Global Health Innovation Fund, Smedvig Ventures, and Octopus Ventures. Use of proceeds has included platform enhancements, new product development, and stated international expansion. Antidote operates as Antidote Technologies, Inc. (USA) and Antidote Technologies Ltd (UK), with no parent entity and no public listing.
Antidote.me firmographics
Firmographics- Name
- Antidote.me
- Legal name
- Antidote Technologies, Inc.
- Website
- https://antidote.me
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Antidote.me operates a dual-sided digital health platform that connects patients with clinical trials through its Antidote Match search engine and provides precision recruitment, enterprise matching, and media services to pharmaceutical sponsors and CROs to accelerate trial enrollment.
- Ownership category
- akta.pro rank
Antidote.me industry classification
Industry- Product category
- Clinical trial patient recruitment
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)
- akta.pro secondary industry
- eConsent & Patient Engagement at Site (HLAGACAI)
Keywords
Where Antidote.me is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Antidote.me business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Sponsors - Trial Recruitment Services: Antidote provides precision recruitment services to pharmaceutical sponsors and clinical trial operators, helping them find and recruit suitable patients for their clinical trials faster.
- Enterprise Match: Enterprise-level clinical trial patient recruitment platform for sponsors requiring larger-scale recruitment capabilities.
- Media Capabilities: Patient engagement and media services to help reach and inform patients about clinical trial opportunities.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Antidote.me product offering
Product offeringCore offering
Antidote.me operates a dual-sided digital health platform that connects patients with clinical trials and helps pharmaceutical sponsors and CROs recruit participants. For patients, Antidote Match is a smart clinical trial search engine that matches individuals to trials based on conditions and eligibility. For sponsors, the company offers Enterprise Match (precision recruitment platform), Trial Recruitment services, and Media Capabilities aimed at accelerating trial enrollment.
Product overview
Antidote.me operates a dual-sided digital health platform consisting of patient-facing and sponsor-facing products. For patients, the core product is Antidote Match, a smart clinical trial search engine that matches individuals to trials based on their conditions and eligibility. For pharmaceutical sponsors, the company offers Enterprise Match (a precision recruitment platform), Trial Recruitment services, and Media Capabilities to accelerate clinical research enrollment. The platform aims to solve the industry problem where over 80% of medical research is delayed due to lack of participants, by connecting patients with appropriate trials through intelligent matching technology.
Differentiator
Problem solved
Functional benefit
Brands
- Antidote Match: Clinical trial patient recruitment platform that helps sponsors fill clinical trials faster through precision recruitment.
Products and services
- Antidote Match (Patient Platform) A smart clinical trial search engine that helps individual patients find clinical trials matched to their medical conditions and eligibility criteria. Aimed at individual patients seeking to participate in research.
- Enterprise Match Enterprise-level clinical trial patient recruitment platform for pharmaceutical sponsors and CROs, providing precision recruitment services to help fill clinical trials faster.
- Trial Recruitment Precision recruitment services designed to help pharmaceutical sponsors fill clinical trials faster, part of Antidote's sponsor solutions suite.
- Media Capabilities Media capabilities offering for sponsors to reach and engage patient populations for clinical trial recruitment purposes.
Quantifiable outcome
- 80%+ of medical research delayed due to lack of participants
Companies that use Antidote.me
Customer profileSegments2 records
Ideal customer profiles2 records
Antidote.me technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Antidote.me partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
Antidote.me competitors and assessment
Company assessmentDirect peers
- Science 37: Science 37 is a decentralized clinical trial operating system enabling remote patient participation and recruitment, directly comparable to Antidote's dual-sided patient recruitment and decentralized trial support model.
- Clara Health: Clara Health is a patient recruitment and clinical trial matching platform serving as a direct comparator to Antidote's patient-facing Match search engine and sponsor recruitment workflow.
- SubjectWell: SubjectWell is a patient recruitment platform connecting clinical trial sponsors with treatment-naive patients through a marketplace model, overlapping with Antidote's patient-acquisition and media capabilities.
- Mendel (Mendel.ai): Mendel applies large language models and clinical reasoning to match patients to clinical trials, directly overlapping with Antidote Match's core precision-recruitment value proposition.
- Castor: Castor is an eClinical platform offering EDC plus patient recruitment and eConsent modules; it competes with Antidote Match on sponsor-facing trial enablement and patient-facing study discovery.
- Deep 6 AI: Deep 6 AI uses AI and EHR data to accelerate clinical trial patient recruitment; it competes directly with Antidote's precision matching approach for sponsor clients.
Broad incumbents
- Veeva Systems: Veeva provides clinical trial and CRM software widely used by pharmaceutical sponsors, including patient and site engagement capabilities that overlap with Antidote's precision recruitment offering.
- Medidata Solutions: Medidata (Dassault Systèmes) provides a unified clinical trial platform including EDC, eCOA, and patient-centric trial tools; it overlaps with Antidote's Enterprise Match recruitment capabilities as part of a larger technology suite.
- IQVIA: IQVIA is the largest CRO globally with broad patient recruitment, real-world data, and site-services offerings; it competes with Antidote at the sponsor enterprise level with significantly broader scale.
Emerging players
- Massive Bio: Massive Bio is an AI-driven oncology-focused clinical trial matching and recruitment firm that uses similar data-driven precision-matching techniques as Antidote, though concentrated in the oncology vertical.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Antidote.me social profiles
Digital presenceAntidote.me financial estimates
Financial estimateRevenue estimate
Valuation estimate
Antidote.me leadership team
Management profileNumber of profiles
Profiles11 records
Antidote.me funding detail
Funding detailFunding overview
Funding rounds6 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Antidote.me M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Antidote.me
What does Antidote.me do?
Antidote.me operates a dual-sided digital health platform that connects patients with clinical trials and helps pharmaceutical sponsors and CROs recruit participants. For patients, Antidote Match is a smart clinical trial search engine that matches individuals to trials based on conditions and eligibility. For sponsors, the company offers Enterprise Match (precision recruitment platform), Trial Recruitment services, and Media Capabilities aimed at accelerating trial enrollment.
Is Antidote.me a public or private company?
Antidote.me is a private company. It is classified as private equity controlled and is currently operating.
When was Antidote.me founded?
Antidote.me was founded in 2010. It employs 11 to 50 people.
Where is Antidote.me based?
Antidote.me is headquartered in London, United Kingdom, in the Europe region.
How does Antidote.me make money?
Three revenue lines are on record. Sponsors - Trial Recruitment Services are the primary driver. The others are enterprise Match and media Capabilities.
Who are Antidote.me's main competitors?
Direct peers on record are Science 37, Clara Health, SubjectWell, Mendel (Mendel.ai), Castor and Deep 6 AI. Broad incumbents are Veeva Systems, Medidata Solutions and IQVIA. Massive Bio is listed as an emerging player.
Does Antidote.me have an API?
No public API is recorded for Antidote.me.
What industry is Antidote.me in?
Antidote.me's product category is Clinical trial patient recruitment. Its primary akta.pro industry code is HLAAANAI, Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials), with a secondary code of HLAGACAI, eConsent & Patient Engagement at Site. Its SIC code is 8731.